mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.061 |
0.8 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.094 |
0.8 |